glp 1 microdosing menopause Microdosing" your GLP-1 is probably not what you think it is. Most people using the term are simply taking a low dose. Those are not the same thing, and the distinction matters Many of you in perimenopause

Pfizer has said it expects pills to eventually capture about a third of the obesity drug market, which is predicted to grow to about $130 billion by the end of the decade.

New FDA regulations and legal actions are phasing out compounded GLP-1s, while companies introduce lower-priced, FDA-approved alternatives.

Results GLP-1R activation increased the CSF secretion rate with an associated elevation of the ICP, whereas inhibition of the receptor reduced the rate of CSF secretion

Michigan Medicaid is tightening GLP-1 coverage in 2025

Time-of-onset analysis revealed no consistent mechanism for the latency of SSIBs in patients receiving GLP-1RAs